# Scholar Rock Holding Corporation (SRRK) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Biotechnology. Price $55.33, market value $6.7 billion.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Scholar Rock Holding Corporation reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / book: 26.5×**. The shares trade at 26.5× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **Free-cash-flow yield: -4.4%** (5-yr avg -11.8%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Return on equity: -154.0%**. Return on equity is negative because earnings are negative.
- **Return on assets: -93.5%**. Each dollar of assets produces -93.5% of profit.

## Growth
- **EPS growth (1 yr): -33.2%**. Earnings per share fell 33.2%.

## Financial health
- **Debt to equity: 0.41**. Debt is 0.41 times equity: a conservative balance sheet.
- **Net debt / EBITDA: 0.6×**. It would take 0.6 years of operating earnings to repay net borrowings, within the comfortable range.
- **Altman Z-score: 23.17**. A Z-score of 23.17 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 1/9**. 1 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Scholar Rock Holding Corporation does not currently pay a dividend.

## Analyst view
- **Analyst consensus: strong_buy** (16 analysts). 16 analysts cover Scholar Rock Holding Corporation; the consensus is strong_buy, with an average price target of $60.75 (+10% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 70.6%** (YTD 25.6%, 3-mo 24.9%). The shares are up 70.6% over twelve months including dividends.
- **From 52-week high: -10.4%** (104.4% above the low). Trading 10% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 52**. An RSI of 52 is neutral.
- **Beta (1 yr): 0.95** (volatility 60%). Beta of 0.95 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=SRRK · Page: https://foliofundamentals.com/stocks/srrk

Not investment advice.